Expert Trading Insights
Unlock the secrets of successful trading with guidance tailored for traders of all levels.
Your Daily Dose of the Doctor
Market Trends
Trading Strategies
Risk Management
Technical Analysis
Economic Indicators
Trading Psychology
Trading Discipline
Learn to check all the boxes and trade with the precision required for profits.
News & Updates
Latest Articles
Lumber Prices Warning Sign
Lumber Prices Are Flashing a Warning Sign for the U.S. Economy TraderInsight • September 9, 2025 • Macro, Housing, Materials Lumber futures have fallen roughly a quarter from early August highs, even as major producers announce output cuts. In past cycles, this type...
Biotech Stocks Year-End Rally
Biotech’s Breakout: Trading XBI Leaders into Year-End Biotech just put up a statement week: the SPDR S&P Biotech ETF (XBI) gained 6% while the broader healthcare ETF (XLV) slipped ~0.8%. When this corner of the market leads, risk appetite is usually...
Lowe’s Housing Rebound
Lowe’s CEO Marvin Ellison Prepares for Housing Rebound Sept 4, 2025 • Based on Barron’s interview with Marvin Ellison Overview Lowe’s CEO Marvin Ellison is positioning the company to seize growth when U.S. housing demand rebounds. Despite today’s sluggish home...
Broadcom AI Order
Broadcom Beats, Lands a New AI Customer — What It Means for Traders At a Glance Fiscal Q3 Revenue $15.95B (beat) Adj. EPS $1.69 (beat) Q4 Revenue Guide $17.4B (above consensus) AI Revenue Trend +63% YoY to ~$5.2B in Q3; mgmt sees further Q4 growth Stock Action Closed...
CDC Turmoil And Vaccine Stocks
CDC Shake-Up Puts Vaccine Trades in Play Washington’s overhaul of the nation’s public-health apparatus is no longer background noise—it’s a live catalyst for vaccine names. This piece explains how CDC turmoil and vaccine stocks intersect with trading tactics you can...
Figma Earnings Miss
Figma earnings miss: What traders need to know now Figma’s first report as a public company came in hot on revenue growth—but cool on expectations—sending shares sharply lower after hours. Below is the fast read for day-traders and swing-traders, followed by deeper...
Alphabet Antitrust Ruling
Alphabet antitrust ruling sends shares to a record high A federal judge issued targeted remedies in the Google search case—no breakup, no ban on default-search payments—fueling a sharp rally in Alphabet and a relief pop in Apple. Updated September 3, 2025 Alphabet...
Trump Administration Locks Intel Into Foundry Business
Trump Administration Locks Intel Into Foundry Business with Equity Stake The Trump administration has taken the unusual step of converting $8.9 billion in Chips Act manufacturing grants into a direct 10 per cent equity stake in Intel, a move designed to keep the...
U.S. Tariffs On Small Packages
Global End of De Minimis: Understanding U.S. tariffs on small packages The U.S. has begun charging duties on all inbound parcels—regardless of value—after suspending the long-standing de minimis waiver. Here’s what changed, why it happened, and how it affects...
Call Walls and Put Walls
Call Walls & Put Walls: The Options Market’s Hidden Support and Resistance How options positioning boxes price, why walls cause reversals, and how to trade the breakouts. Options walls can “box in” prices: a call wall (resistance) is positioned above, and a put...
Spirit Airlines Bankruptcy
Spirit Airlines Bankruptcy: What’s Behind the Troubles and Can It Recover? A look at the latest Chapter 11 filing, the causes of the crisis, and the airline’s chances of recovery. Only months after emerging from restructuring, Spirit Airlines bankruptcy headlines are...
Tesla European Sales
Tesla European Sales Slide 34%, Yet Shares Rise on AI Momentum New data shows that Tesla's European sales dropped sharply in July 2025, but investor enthusiasm surrounding AI and robo-taxi innovation continues to buoy the stock. Here’s what that means for markets —...
U.S. economy expanded 3.3% in Q2
GDP Surprise: Q2 Growth Revised Up, Inflation Steady — A Trader’s Read The Commerce Department’s second estimate shows stronger-than-first-reported momentum in Q2 as consumers kept spending and net trade dynamics flattered the headline. Below: what changed, why it...
Nvidia Earnings Beat Expectations
Nvidia Earnings Beat Expectations, But Stock Falls Nvidia earnings beat expectations in the company’s latest quarterly report, but shares slipped in extended trading despite the upbeat results and guidance. The chipmaker continues to dominate the artificial...
Snowflake Stock Jumps On Earnings
Snowflake Stock Jumps on Earnings: What Traders Need to Know Snowflake stock jumps on earnings after the cloud-based data platform delivered results that far exceeded Wall Street’s expectations. Shares surged more than 12% in after-hours trading as investors responded...
Kohl’s Earnings Beat and Stock Surge
Kohl’s Earnings Beat and Stock Surge: What Traders Should Watch Now A 20% pop puts Kohl’s earnings beat and stock surge in the spotlight, but leadership uncertainty and declining sales keep the turnaround thesis on trial. Date: August 27, 2025 • Ticker: KSS • Sector:...
Nvidia earnings and the future of the AI trade
Nvidia Earnings: What Traders Should Watch and How AI’s Future Hangs on Cash Flow NVDA’s report is a referendum on the AI trade—watch China guidance, supply–demand balance, and hyperscaler capex. The catch: free cash flow across Big Tech is straining just as AI...
Nvidia Earnings AI Stock Trading
Nvidia Earnings: A $4 Trillion AI Test for Wall Street Why Nvidia’s Earnings Matter Nvidia, the world’s most valuable public company, reports results today after the bell, and the stakes could not be higher. With a market capitalization of $4 trillion, Nvidia is not...
India Russian Oil US Tariffs
India Holds Firm on Russian Oil as US Tariff Threats Loom Key Developments The Trump administration is preparing to impose punitive tariffs of up to 50% on Indian exports in response to New Delhi’s ongoing purchases of Russian crude oil. A planned US trade delegation...
Eli Lilly Orforglipron Diabetes Trial Weight-Loss Pill
Eli Lilly’s Orforglipron Hits Target in Diabetes Trial—Oral GLP-1 Battle with Novo Nordisk Heats Up Key Takeaways 10.5% average weight loss in overweight/obese patients with Type 2 diabetes over ~72 weeks on orforglipron; GI side effects broadly in line with...
Japanese Stocks Soar Despite Tariffs
Japanese Stocks Soar Despite Tariffs and Turmoil (Aug 2025) EWJ and key indices in Tokyo keep climbing even as the U.S. locks in 15% reciprocal tariffs and Japan’s ruling coalition loses its upper‑house majority. Here’s what’s driving the rally—and how to trade it....
Fast vs. Reflective Decisions in Trading
The MTRI Impulsivity Dimension: Fast vs. Reflective Decisions in Trading Our background in behavioral finance has had Traderinsight.com focused on the psychological development of traders for three decades. It's only a recent evolution that has media outlets like...
Estée Lauder Stock Plummets
Estée Lauder Stock Plummets: Weak Guidance Spooks Investors Estée Lauder stock (EL) plummets after the cosmetics giant reported in-line earnings but issued soft guidance for the fiscal year ahead. Despite adjusted EPS of $0.09 on revenue of $3.41B—both in line with...
Target CEO Change Overshadows Earnings
Target CEO Change Overshadows Earnings: What Day Traders Should Watch Target posted a slight Q2 beat, but price action says the leadership shift is the real catalyst. Here’s how to trade the reaction—because in the short term, Target CEO change overshadows earnings....
Meme Stock Pump-and-Dump Scams
Meme Stock Pump-and-Dump Scams: A Day Trader’s Survival Guide In July, a fresh wave of meme-stock “ramps” rocketed thinly traded microcaps before collapsing just as fast—leaving billions in paper wealth erased and a trail of retail accounts blown up. Here’s what...
Advance Auto Parts Earnings Day Trading Setup
Advance Auto Parts (AAP) After Earnings: A Deeper Dive and Day-Trading Playbook Advance Auto Parts posted an EPS beat but guided 2025 lower as interest expense rises following a $1.95B notes offering. The stock’s third straight double-digit post-earnings move makes...
Oracle Earnings Day Trading Setup
Oracle’s AI Rally Pauses: A Deeper Dive with Day-Trading Setups Oracle (ORCL) slipped more than 4% to ~238 after a torrid June–July run that peaked at 260.87. Price is now decisively below the 21-day moving average while still hovering a few percent above the 50-day,...
MTRI Neuroticism Dimension: Emotional Reactivity and Trading
The MTRI Neuroticism Dimension in Trading: How Emotional Reactivity Shapes Decisions In our last article, we looked at how the Manz Trader Readiness Inventory can be used as a tool for traders to understand how their psychology affects performance. Today, we will...
Merck Keytruda Medicare Delay and MRK Day Trading Opportunity
Merck Keytruda Medicare Delay: What It Means for Day Traders The recent tweak to Medicare’s drug price negotiation program has given Merck (MRK) a brief lifeline. While long-term investors are debating whether the change truly softens the looming Keytruda patent...
Merck Keytruda Medicare Delay
A Tweak to Medicare is Good for Merck. But Can It Revive the Stock? Merck & Co. has found a small reprieve in Washington, but investors remain skeptical that it will meaningfully alter the company’s trajectory. A new tweak to Medicare’s drug price negotiation...
September Fed rate cut and day trading
September Fed Rate Cut: Why Day Traders Should Prepare for a Hawkish Surprise Fed expectations vs. market reality The S&P 500, currently hovering above 6400, has rallied on expectations of a September Fed rate cut. Fed funds futures are pricing an 85% chance of a...
Measuring Psychological Fitness for Day Trading
The Manz Trader Readiness Inventory: Measuring Psychological Fitness for Day Trading Success in day trading is about much more than mastering technical setups or memorizing chart patterns. While strategy and execution are essential, they’re only part of the equation....
Trump Considers 10% Government Stake In Intel
Intel Government Stake Talks and Day Trading Implications The Trump administration is reportedly considering a 10% equity stake in Intel (INTC), which would convert billions in CHIPS Act funding into ownership. The proposal underscores Washington’s deepening...
Retail Earnings Tariffs and Day Trading Insights
Retail Earnings, Tariffs, and Day Trading: Where the Real Risk Lies Why this week matters Headline numbers may look fine; the risk is guidance as retailers speak to the back half (B2S and holiday). Tariff pass-through is the swing factor: modest so far, but price...
Novo Nordisk Wegovy MASH approval
Novo Nordisk Wegovy MASH approval: Why NVO is jumping—and how day traders can trade it Quick take Novo Nordisk shares pop after the FDA grants accelerated approval for Wegovy to treat MASH (metabolic dysfunction-associated steatohepatitis) with liver fibrosis in...
DeepSeek AI Model Delay
DeepSeek’s AI Model Delay and the Impact on Intraday Trading Opportunities China’s AI Ambitions Face Technical Headwinds The delay in the DeepSeek AI model underscores a significant challenge in Beijing’s push to reduce reliance on U.S. technology. The Chinese AI...
Weight-Loss Drug Stocks
Weight-Loss Drug Stocks and Day Trading Opportunities Pharma’s Former Darling Turns Volatile The meteoric rise of weight-loss drug stocks such as Novo Nordisk and Eli Lilly was once seen as a safe haven in the pharmaceutical sector. Fueled by the popularity of GLP-1...
Zelensky–Trump Meeting Market Impact
Zelensky–Trump Meeting Market Impact: What Traders Should Expect As President Volodymyr Zelensky returns to Washington with a cohort of European leaders, the Zelensky–Trump meeting market impact will hinge on three things: the shape of potential security guarantees,...
Big Tech AI Talent War
Big Tech AI Talent War: How Reverse Acquihires Could Reshape Silicon Valley The Big Tech AI talent war is pushing Microsoft, Meta, Google and others to pursue a new playbook—poach founders and core researchers, license the IP, and leave the startup shell behind. It’s...
Disney and Marvel leaving Georgia
Disney and Marvel Leaving Georgia: Intraday Stock Action & What It Means for Cleveland What Happened (and Why It Matters) Reports indicate Disney’s Marvel is shifting most big-budget productions away from Georgia and toward the United Kingdom, citing a better...
Trump’s Emerging Market Behavior: How It Could Hit Markets
Trump’s Emerging Market Behavior: Is the US Beginning to Look Like Argentina? For decades, the United States has been the world’s benchmark for financial stability, transparency, and institutional independence. Yet in President Donald Trump’s second term, analysts and...
Housing Market Correction Indicators
Housing Market Correction Indicators: 3 Key Trends to Watch Despite appearing stagnant on the surface, the U.S. housing market is showing early signs of a potential shift—and possibly a correction. Economists are closely monitoring several key indicators to assess...
Uber’s Autonomous Ambitions Impact TSLA
Uber’s Autonomous Ambitions Spark Tesla Volatility: What Traders Need to Watch Shares of Uber Technologies (UBER) climbed in early trading Wednesday after the company posted strong second-quarter earnings, beat across key metrics, and unveiled a $20 billion share...
Pfizer Raises Guidance Amid Drug Pricing Pressure
Pfizer Raises Guidance Amid Drug Pricing Pressure: What Traders Should Know Pfizer (PFE) raised its full-year earnings guidance this week, signaling early success in its multibillion-dollar cost-cutting strategy while navigating political pressure from President...
Teradyne stock performance 2025
Teradyne Leads the S&P 500 After Strong Earnings and AI Momentum Teradyne (TER) shares surged Wednesday, topping the S&P 500 leaderboard after the company delivered solid second-quarter results and projected accelerating growth tied to artificial intelligence...
Super Micro (SMCI) Slashes Guidance
Super Micro (SMCI) Slashes Guidance—And Still Misses the Mark for Wall Street Shares of Super Micro Computer Inc. (SMCI) plunged over 17% in premarket trading Wednesday after the company lowered its full-year revenue forecast and offered little reassurance on margins,...
Ford Faces $2 Billion Tariff Hit as Profit Outlook Slumps, EV Strategy in Spotlight
Ford tariff impact 2025 Ford Motor Co. is feeling the sting of rising trade tensions. On Wednesday, the automaker warned investors that tariff-related costs are now expected to total $2 billion in 2025—a $500 million increase from its previous estimate in May. While...
Trump’s EU Deal Leaves Markets Guessing
Trade Truce or Powder Keg? Trump’s EU Deal Leaves Markets Guessing In a week already brimming with geopolitical uncertainty, a fragile U.S.–EU trade agreement has injected fresh volatility into global markets. European Union officials announced that they would suspend...
Intel’s new CEO, Lip-Bu Tan at the center of a high-stakes battle
Intel CEO Lip-Bu Tan Faces Internal Rift, Political Pressure, and Strategic Crossroads Intel’s new CEO, Lip-Bu Tan, has been in the job for just a few months, but already finds himself at the center of a high-stakes battle — one that spans boardroom disputes,...
Driverless Trucks Hit the Night Shift on Texas Highways
A new chapter in U.S. freight transport is unfolding under the stars. Autonomous trucks are now running overnight routes on some of Texas’s busiest highways, thanks to Aurora Innovation, a company pushing the boundaries of self-driving technology. The company’s...
Common Questions About The Doctors Dose
What topics are covered in The Doctors Dose?
The Doctors Dose includes a wide range of topics such as market analysis, trading strategies, and expert insights to help you make informed trading decisions.
How often is new content added to The Doctors Dose?
New articles and insights are added daily, ensuring you have the latest information and strategies at your fingertips.
Who writes for The Doctors Dose?
Our content is crafted by seasoned traders and financial experts who share their knowledge and experience to empower our readers.
Can I suggest topics for The Doctors Dose?
Absolutely! We welcome suggestions from our readers. Feel free to contact us with your ideas and feedback.
Is The Doctors Dose suitable for beginners?
Yes, we provide content that caters to all levels, from beginners to advanced traders, ensuring everyone can benefit from our insights.
Explore More with TraderInsight
Unlock a wealth of knowledge and take your trading skills to the next level with TraderInsight.academy. Dive into our expert resources and start your journey towards successful trading today.